LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway

Hepatocellular carcinoma: clinical frontiers and perspectives

(2014) Jordi Bruix et al.   GUT

Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance

(2014) Hariharan Easwaran et al.   MOLECULAR CELL

The fundamental role of mechanical properties in the progression of cancer disease and inflammation

(2014) Claudia Tanja Mierke   REPORTS ON PROGRESS IN PHYSICS

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

(2014) Amit G. Singal et al.   PLOS MEDICINE

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma

(2013) Guang-Zhi Jin et al.   JOURNAL OF HEPATOLOGY

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

(2012) Dahu Chen et al.   NATURE MEDICINE

Oct-3/4 promotes migration and invasion of glioblastoma cells

(2011) Kana Kobayashi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways

(2011) Min Huan Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

iTRAQ–2DLC–ESI–MS/MS Based Identification of a New Set of Immunohistochemical Biomarkers for Classification of Dysplastic Nodules and Small Hepatocellular Carcinoma

(2011) Guang-Zhi Jin et al.   JOURNAL OF PROTEOME RESEARCH

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array

(2009) Yukiyasu Okamura et al.   CANCER LETTERS

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer

(2008) Bin Zhang et al.   BMC CANCER